id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0007-0005,FDA,FDA-2012-N-0007,Generic Drug User Fee: Backlog Fee Rate for Fiscal Year 2013,Notice,General Notice,2012-10-25T04:00:00Z,2012,10,2012-10-25T04:00:00Z,,2012-10-25T16:40:46Z,2012-26257,0,0,090000648115020e
FDA-2012-N-0007-0004,FDA,FDA-2012-N-0007,"Generic Drug User Fee: Abbreviated New Drug Application, Prior Approval Supplement, and Drug Master File Fee Rates for Fiscal Year 2013",Notice,General Notice,2012-10-25T04:00:00Z,2012,10,2012-10-25T04:00:00Z,,2012-10-25T16:36:51Z,2012-26256,0,0,0900006481150373
FDA-2012-N-0007-0003,FDA,FDA-2012-N-0007,Fee for Using a Priority Review Voucher in Fiscal Year 2013,Notice,General Notice,2012-09-13T04:00:00Z,2012,9,2012-09-13T04:00:00Z,,2012-09-13T13:12:24Z,2012-22587,0,0,0900006481114cd5
FDA-2012-N-0007-0001,FDA,FDA-2012-N-0007,Biosimilar User Fee Rates for Fiscal Year 2013,Notice,General Notice,2012-08-01T04:00:00Z,2012,8,2012-08-01T04:00:00Z,,2012-08-01T16:50:14Z,2012-18712,0,0,09000064810bc377
FDA-2012-N-0007-0002,FDA,FDA-2012-N-0007,Prescription Drug User Fee Rates for Fiscal Year 2013,Notice,General Notice,2012-08-01T04:00:00Z,2012,8,2012-08-01T04:00:00Z,,2012-08-01T16:56:20Z,2012-18711,0,0,09000064810bc437